drugset / Trial / NCT00054249
T900607 in Treating Patients With Gastroesophageal Junction Cancer
Phase 2
Completed
University Hospitals Seidman Cancer Center
National Cancer Institute (NCI) · collab
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of T900607 in treating patients who have gastroesophageal junction cancer.
Timeline
- Start
- 2002-09
- Primary completion
- 2004-10
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | T900607 | Small molecule | — | Intravenous |